Onconova Therapeutics to Provide Corporate Update and Full Year 2019 Financial Results
NEWTOWN, Pa., March 18, 2020 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused […]
Helius Medical Technologies Announces $2.2 Million Registered Direct Offering
NEWTOWN, Pa., March 18, 2020 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech […]
Enlivex Announces Positive Final Safety and Efficacy Data From Clinical Trial of Off-The-Shelf Allocetra in Patients with Severe Sepsis
– Final Analysis Comparing 10 AllocetraTM-Treated Patients with 37 Matched Controls Showed Significant Positive Responses in State of Organ Failure, […]
Anchiano Therapeutics Reports Year-End 2019 Financial Results
CAMBRIDGE, Mass., March 18, 2020 (GLOBE NEWSWIRE) — Anchiano Therapeutics Ltd. (Nasdaq: ANCN) (“Anchiano”), a biopharmaceutical company focused on discovery […]
TSX News -
InPlay Oil Corp. Announces its 2019 Financial, Operating and Reserves Results Highlighted by a 20% Increase in Adjusted Funds Flow over 2018
CALGARY, Alberta, March 18, 2020 (GLOBE NEWSWIRE) — InPlay Oil Corp. (TSX: IPO) (OTCQX: IPOOF) (“InPlay” or the “Company”) is […]
TSX News -
Husky Energy Reports Results of Series 5 Preferred Share Conversion
CALGARY, Alberta, March 18, 2020 (GLOBE NEWSWIRE) — Husky Energy announces that 40,800 Cumulative Redeemable Preferred Shares, Series 5 (Series […]
ARHT Media Launches Virtual Global Stage™
Virtual Global Stage™ (“VGS™”) is a premium digital on-stage experience online that eliminates the need for a venue, travel, or the […]
BioSyent Releases Results for Fourth Quarter and Full Year 2019
MISSISSAUGA, Ontario, March 18, 2020 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today a summary of its […]
Siyata Mobile Announces Update on Public Safety Supply Chain
MONTREAL, March 18, 2020 (GLOBE NEWSWIRE) — Siyata Mobile Inc. (the “Company” or “Siyata”) (TSX-V:SIM / OTCQX:SYATF) announces that the […]
iBio Announces Development of Proprietary COVID-19 Vaccine Candidates
NEW YORK, March 18, 2020 (GLOBE NEWSWIRE) — iBio, Inc. (NYSE AMERICAN:IBIO) (“iBio” or the “Company”), a biologics contract manufacturing […]
